Trials / Completed
CompletedNCT00903253
A Double-Blind, Placebo Controlled, Single, Escalating Dose Study to Evaluate the Preliminary Pharmacokinetics, Safety and Tolerability of LNK-754 in Healthy Elderly Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Link Medicine Corporation · Industry
- Sex
- All
- Age
- 60 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to evaluate the single-dose plasma pharmacokinetics of LNK-754 as well as safety and tolerability in normal healthy male and female elderly volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LNK-754 |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2009-05-18
- Last updated
- 2009-09-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00903253. Inclusion in this directory is not an endorsement.